RecruitingNCT06719583

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Black and African Americans Connections to Parkinson's Disease (BLAAC PD) A Project of the Global Parkinson's Genetics Program (GP2)


Sponsor

Michael J. Fox Foundation for Parkinson's Research

Enrollment

2,000 participants

Start Date

Nov 16, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities. BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is working to better understand Parkinson's disease in Black and African American communities, who have historically been underrepresented in research. Researchers are collecting data and biological samples (like saliva) to study genetic, environmental, and social factors that may influence the development and progression of Parkinson's disease in this population. **You may be eligible if (as a healthy control participant)...** - You are 50 years or older - You self-identify as Black or African American - You do not have Parkinson's disease or any known neurological condition - You do not have a family history of Parkinson's or other neurodegenerative disorders **You may be eligible if (as a participant with Parkinson's disease)...** - You are 18 years or older - You self-identify as Black or African American - You have been diagnosed with Parkinson's disease based on standard clinical criteria **You may NOT be eligible if...** - You have a known neurological condition (for the control group) - You have family history of neurodegenerative disease (for the control group) - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(12)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of Florida

Gainesville, Florida, United States

Rush University

Chicago, Illinois, United States

University of Chicago

Chicago, Illinois, United States

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

Louisiana State University Health Sciences Center Shreveport

Shreveport, Louisiana, United States

University of Maryland

Baltimore, Maryland, United States

Kaiser Permanente Midatlantic States

Rockville, Maryland, United States

Washington University in St. Louis

St Louis, Missouri, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Medical University of South Carolina

Charleston, South Carolina, United States

University of Texas Health Science Center, Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06719583


Related Trials